Investor · Salt Lake City, UT

Kent Gordon

Open Kent in the network graph →

Filings

10

SEC Form D

Connections

49

co-filers

Capital

$29.3M

across filings

Active

Aug 2019

to Jul 2024

Most-connected co-filers (49)

William Dorsey · Parsippany, NJ7 shared Richard Smith · Orem, UT7 shared Mark Levine · Washington D.C., Washington, D.C.5 shared Riyas Nooruddin · Camana Bay, Grand Cayman, Cayman Islands5 shared Paras P. Malde · Grand Cayman, Cayman Islands5 shared Mohammed Salama · Orem, UT5 shared Raj Mehra · New York, NY4 shared Richard W. Pascoe · Celebration, FL4 shared Brian Lian · New York, NY4 shared Dalibor Sames · New York, NY3 shared Sylvester O'Byrne · Paris, I03 shared Michael W. Golembiewski · New York, NY3 shared Margot Lyons · Paris, I03 shared Gautam Shah · Cedar Park, TX3 shared Edward Harycki · Bryn Mawr, PA3 shared Gaurav Sahni · Short Hills, NJ3 shared Julie B. Sanders · Dallas, TX3 shared Jonathan Sporn · New York, NY3 shared Richard M. Craib · San Francisco, CA3 shared Andrew Kruegel · New York, NY3 shared James T. Farrell · San Francisco, CA3 shared Margaret Dalesandro · San Diego, CA3 shared Michael Aicher · Orem, UT2 shared James Drake · Plymouth, MN2 shared

Recent filings (10)

SEELOS THERAPEUTICS, INC.Jul 2024 · 14 co-filers$1.1M SEELOS THERAPEUTICS, INC.May 2024 · 14 co-filers$2.0M SEELOS THERAPEUTICS, INC.Feb 2024 · 17 co-filers$3.6M Techcyte, Inc.Jan 2024 · 24 co-filers$8.4M Techcyte, Inc.Aug 2021 · 24 co-filers$20.9M Gilgamesh Pharmaceuticals, Inc.May 2021 · 13 co-filers$34.7M Gilgamesh Pharmaceuticals, Inc.Sep 2020 · 8 co-filers SEELOS THERAPEUTICS, INC.Sep 2020 · 13 co-filers$5.6M Gilgamesh Pharmaceuticals, Inc.Aug 2020 · 8 co-filers SEELOS THERAPEUTICS, INC.Aug 2019 · 9 co-filers$4.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Kent in the interactive graph →